ASCO 2017- Denosumab compared with zoledronic acid on renal function in the treatment of myeloma bone disease

Impact of denosumab compared with zoledronic acid on renal function in the treatment of myeloma bone disease Author: InternationalMyelomaFoundation Added: 08/15/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts